VDR agonist 2 (compound 16i), a vitamin D receptor (VDR) agonist, effectively inhibits TGF-beta1-induced hepatic stellate cell (HSC) activation, demonstrating notable anti-hepatic fibrosis efficacy both in vitro and in vivo [1].
Molecular Weight:
366.37
Formula:
C20H21F3O3
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
